nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—Clobetasol propionate—CYP1A1—head and neck cancer	0.4	0.4	CrCbGaD
Loteprednol—Triamcinolone—PTGS2—head and neck cancer	0.196	0.196	CrCbGaD
Loteprednol—Betamethasone—PTGS2—head and neck cancer	0.161	0.161	CrCbGaD
Loteprednol—Dexamethasone—CYP1A1—head and neck cancer	0.15	0.15	CrCbGaD
Loteprednol—Dexamethasone—PTGS2—head and neck cancer	0.0935	0.0935	CrCbGaD
